About us


The fruit of a collaboration between industry and research

The development of Neolys Diagnostics tests is the result of a meeting between industry and radiobiology researchers from Lyon (INSERM unit).

A reliable technology

First of all, our team has developed a reliable technology, based on the implementation of predictive tests, allowing the personalization of radiotherapy treatments.

We are responding to a need: to predict the radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities.


We promote fundamental values, characteristic of our commitment and our work: the respect of biomedical ethics, a will to improve patients’ care and quality of life

These values are reflected in our actions:

  • Treatment optimization
  • Prevention of environmental or medical-related toxicity
  • Innovations to broaden our scope 
Learn more about our solutions

Our Team

Our team is mainly composed of professional biology researchers, specialized in radiobiology. 

A unique know-how

All our team members share a deep knowledge of individual radiosensitivity. 

Sandrine Pereira

Director of R&D

PhD in radiobiology, Sandrine is also an industrial transfer and medical devices specialist. She supervises the R&D department of the company.

Elise Berthel

R&D Project Manager

PhD in radiobiology, Elise supervises the company’s research and development unit.

Mirlande Duclos

Laboratory technician

Mirlande takes part in R&D experiments and is specialized in performing radiosensitivity tests.

Patrick Barhoum

Business Developer

Phd in science specialising in chemistry and biology and a master's degree in innovation management. Patrick is in charge of business development.

Our scientific partners

Follow us
Laboratory form